Globus Medical, Inc. is a healthcare company.
Globus Medical, Inc. (GMED) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 16:22 ET. Consensus EPS estimate is $1.20.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | FY2026 Q2 | $1.10 | $1.12 | +1.8% | $789.61M |
| 2026-05-07 | FY2026 Q1 | $0.92 | $0.92 | +0.0% | $759.85M |
| 2026-02-24 | FY2025 Q4 | $1.06 | $1.05 | -0.9% | $826.39M |
| 2025-11-06 | FY2025 Q3 | $0.78 | $0.88 | +12.7% | $769.05M |
| 2025-08-07 | FY2025 Q2 | $0.76 | $1.50 | +97.4% | $745.34M |
| 2025-05-08 | FY2025 Q1 | $0.74 | $0.55 | -26.1% | $598.12M |
| 2025-02-20 | FY2024 Q4 | $0.74 | $0.84 | +13.5% | $657.29M |
| 2024-11-05 | FY2024 Q3 | $0.65 | $0.38 | -41.3% | $625.71M |
GMED has beaten consensus EPS in 5 of its last 8 reported quarters.
GMED reported Aug 6. The highlights: EPS of $1.12 — in line with the $1.10 estimate; revenue of $790M — in line with the $783M consensus. Focus now shifts to robot placements and integration.
See GMED on the live calendar →